Sort
82,697 grants matching “vaccine development”
DEVELOPMENT OF A UNIVERSAL MRNA VACCINE TARGETING APC MUTATIONS FOR COLORECTAL CANCER PREVENTION
$698,456Sloan-Kettering Institute For Cancer Research · · FY2024 · Defense Health Agency
Diagnosing and predicting risk in children with SARS-CoV-2- related illness
$698,415Jane C Burns · University Of California, San Diego · R61 · FY2021 · HD
NONHUMAN PRIMATE CORE QUANT IRAL RNA LABORATORY FOR AIDS VACCINE R&D
$698,400Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
Undetected Drug resistance and Tolerance in lesions of recurrent TB
$698,346Faramarz Valafar · San Diego State University · R01 · FY2023 · AI
Innate Restriction Factor Modulation of Retrovirus-specific Humoral Immunity
$698,338Mario Luis Santiago · University Of Colorado Denver · R01 · FY2012 · AI
Epidemiology of Helicobacter Pylori Transmission
$698,295Julie Parsonnet · Stanford University · R01 · FY2009 · AI
Epitope Driven HIV Vaccine Development
$698,286Brown University · R01 · FY2002 · AI
Modification Of The Antigenicity & Virulence Of Rotaviruses By Reverse Genetics
$698,282John Patton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Tuberculosis and T cell Recognition
$698,256Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · AI
Biology of human cytotoxic CD4 T cells (CD4-CTLs) in viral infections
$698,113Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2023 · AI
Development of Novel Antiviral Agents VS West Nile Virus
$698,106Michael S. Diamond · Washington University · U01 · FY2006 · AI
Structure and lineage-based immunogen design scientific research support compone
$698,095Stephen C Harrison · Duke University · UM1 · FY2012 · AI
A Novel Approach to RSV Vaccination
$698,083Joan E. Durbin · New York University School Of Medicine · R01 · FY2010 · AI
A risk-varying and perturbed self-controlled case series design for assessing the safety of COVID-19 vaccines in a large health care system
$698,072Stanley Xu · Kaiser Foundation Research Institute · R01 · FY2025 · AI
Pathology
$698,048Ashley T. Haase · Beth Israel Deaconess Medical Center · U19 · FY2013 · AI
Nanotechnology-based cardiovascular vaccines
$698,017Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2025 · HL
Primate Core
$698,006Hans-Peter Kiem · University Of Southern California · U19 · FY2022 · HL
Curaxin-137, A New Lead for Anti-Trypanosome Drug Discovery - Resubmission - 1
$697,985Kojo Mensa-Wilmot · University Of Georgia · R01 · FY2017 · AI
Administrative Core
$697,854David B. Weiner · Wistar Institute · U19 · FY2025 · AI
Mechanisms of naturally-acquired immunity to malaria
$697,832Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
MAb Passive Vaccination against Acinetobacter baumannii
$697,793Brad J Spellberg · University Of Southern California · R01 · FY2020 · AI
Task Order 9 Master Cell Bank for Chlamydia Trachoma Vaccine
$697,764James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
Antigenic determinants of asthma-associated allergens for design of immunotherapy.
$697,759Anna Pomes · Indoor Biotechnologies · R01 · FY2016 · AI
Intensifying Community Referrals for Health: The SINCERE Intervention to Address COVID-19 Health Disparities
$697,753Andrea Schneider Wallace · University Of Utah · R01 · FY2021 · NR
Attacking the Immunopeptidome of Ewing Sarcoma
$697,731Crystal Mackall · Stanford University · U01 · FY2025 · CA